Incidence, treatment, and outcomes of acute myocardial infarction following transcatheter or surgical aortic valve replacement.
Toshiaki IsogaiAnas M SaadKeerat Rai AhujaShashank ShekharOmar M AbdelfattahMohamed M GadLars G SvenssonAmar KrishnaswamyGrant W ReedRishi PuriE Murat TuzcuStephen G EllisSamir R KapadiaPublished in: Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions (2021)
AMI, albeit uncommon, was more frequent post-TAVR than post-SAVR. Patients commonly presented with NSTEMI, but the mortality of STEMI was markedly high. Further studies are needed to understand why a substantial percentage of patients do not receive invasive coronary treatment, particularly after TAVR, despite seemingly better outcomes with invasive strategy.
Keyphrases
- aortic stenosis
- ejection fraction
- acute myocardial infarction
- aortic valve replacement
- end stage renal disease
- aortic valve
- newly diagnosed
- chronic kidney disease
- transcatheter aortic valve replacement
- coronary artery disease
- percutaneous coronary intervention
- left ventricular
- coronary artery
- adipose tissue
- heart failure
- risk factors
- type diabetes
- metabolic syndrome
- patient reported outcomes
- acute coronary syndrome
- atrial fibrillation